Functional significance of a C–>A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

Cited by (749)

Items 201–300 of 749

1. Cytochrome P450 polymorphisms and response to antipsychotic therapy
   Maria Gabriella Scordo, Edoardo Spina · 2002 · Pharmacogenomics
2. Caffeine, alcohol, smoking, and reproductive outcomes among couples undergoing assisted reproductive technology treatments
   Mínguez-Alarcón, Lidia, Chavarro, Jorge E., Gaskins, Audrey J. · 2018 · Fertility and Sterility
3. Clinical Predictors of High Posttreatment Platelet Reactivity to Clopidogrel in Koreans
   Kyung Woo Park, Jin Joo Park, Ki‐Hyun Jeon, Si‐Hyuck Kang, Il‐Young Oh, Han‐Mo Yang, Hyun‐Jai Cho, Hae‐Young Lee, Hyun‐Jae Kang, Bon‐Kwon Koo et al. · 2010 · Cardiovascular Therapeutics
4. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients
   Yan Hong Huang Fu, Changhe Fan, Hehuang Deng, San-hong Hu, De-peng LV, Lihua Li, Jijun Wang, Xin-qiao LU · 2006 · Acta Pharmacologica Sinica
5. Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study
   Iris Grossman, Patrick F. Sullivan, Nicole Walley, Youfang Liu, Jeffrey R. Dawson, Curtis E. Gumbs, Andrea Gaedigk, James Steven Leeder, Joseph P. McEvoy, Michael E. Weale et al. · 2008 · Genetics in Medicine
6. Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk
   Jun Wang, Amit D. Joshi, Román Corral, Kimberly D. Siegmund, Loı̈c Le Marchand, Marı́a Elena Martı́nez, Robert W. Haile, Dennis J. Ahnen, Robert S. Sandler, Peter Lance et al. · 2011 · International Journal of Cancer
7. Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
   Patrick Vizeli, Isabelle Straumann, Friederike Holze, Yasmin Schmid, Patrick C. Dolder, Matthias E. Liechti · 2021 · Scientific Reports
8. High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic Drug
   Elisabeth Skogh, Ingemar Sjödin, Martin Josefsson, Marja­‐Liisa Dahl · 2010 · Journal of Clinical Psychopharmacology
9. CYP1A2, GSTM1, andGSTT1Polymorphisms and Diet Effects on CYP1A2 Activity in a Crossover Feeding Trial
   Sabrina P. Trudo, Yvonne Schwarz, Shuying S. Li, Lin Li, Irena B. King, Chu Chen, David L. Eaton, John D. Potter, Johanna W. Lampe · 2009 · Cancer Epidemiology Biomarkers & Prevention
10. Effects of Common CYP 1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis
    Dandan Tian, Senthil Natesan, John Raymond White, Mary F. Paine · 2018 · Clinical and Translational Science
11. Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies
    Espen Molden · 2021 · Expert Opinion on Drug Metabolism & Toxicology
12. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking
    Eline M. Rodenburg, Mark Eijgelsheim, Johanna Marianne Geleijnse, Najaf Amin, Cornelia M. van Duijn, Albert Hofman D, André Gerardus Uitterlinden, Bruno H. Ch. Stricker, Loes E. Visser · 2012 · American Journal of Clinical Nutrition
13. Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake
    Emily Urry, Alexander Jetter, Hans‐Peter Landolt · 2016 · Nutrition & Metabolism
14. Effects of CYP1A2 and ADORA2A Genotypes on the Ergogenic Response to Caffeine in Professional Handball Players
    Alejandro Muñoz, Álvaro López‐Samanes, Millán Aguilar‐Navarro, David Varillas‐Delgado, Jesús Rivilla-García, Víctor Moreno-Pérez, Juan Del Coso · 2020 · Genes
15. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study
    Chi‐Chen Hong, Bing-Kou Tang, Geoffrey L. Hammond, David Tritchler, Martin J. Yaffe, Norman F. Boyd · 2004 · Breast Cancer Research
16. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
    Hsien‐Yuan Lane, Cheng-Chun Lee, Yi‐Ching Liu, Wen‐Ho Chang · 2005 · Pharmacogenomics
17. Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda
    L. Christiansen, Anette Bygum, A. Jensen, K Thomsen, F Brandrup, Mogens Hørder, Niels Erik Petersen · 2000 · Human Genetics
18. Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers
    Tabassome Simon, Laurent Becquemont, Brigitte Hamon-Vilcot, Emmanuel Nouyrigat, Y. Chodjania, Jean‐Marie Poirier, Christian Funck‐Brentano, Patrice Jaillon · 2001 · British Journal of Clinical Pharmacology
19. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans
    Sun‐Young Bae, Sun‐Keun Choi, Kyung‐Rae Kim, Chang‐Shin Park, Sung‐Keun Lee, Hyung‐Keun Roh, Dong-Woon Shin, Jae‐Eun Pie, Ze‐Hong Woo, Ju‐Hee Kang · 2006 · Cancer Science
20. Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women
    Natalia Palacios, Marc G. Weisskopf, K. Simon, Xiang Gao, Michael A. Schwarzschild, Alberto Ascherio · 2010 · Parkinsonism & Related Disorders
21. Pharmacogenetics of Olanzapine Metabolism
    Mao Mao Söderberg, Marja­‐Liisa Dahl · 2013 · Pharmacogenomics
22. Theophylline: a review of population pharmacokinetic analyses
    Y. J., D. Q. Jiang, J. X. Meng, M. X. Li, Haijin Zhao, Y. Wang, L. Q. Wang · 2016 · Journal of Clinical Pharmacy and Therapeutics
23. Effects of type of smoking (pipe, cigars or cigarettes) on biological indices of tobacco exposure and toxicity
    Christian Funck‐Brentano, Mathilde Raphael, Michel Lafontaine, J P Arnould, Céline Verstuyft, Martine Lebot, Dominique G. Costagliola, Ronan Roussel · 2006 · Lung Cancer
24. What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?
    Vural Özdemir, Neil H. Shear, WERNER KALOW · 2001 · Drug Safety
25. Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
    Patrick Vizeli, Yasmin Schmid, Katharina Prestin, Henriette E. Meyer zu Schwabedissen, Matthias E. Liechti · 2017 · European Neuropsychopharmacology
26. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
    Yasunori Osawa, Kayo Osawa, Aiko Miyaishi, Miho Higuchi, Akimitsu Tsutou, Sueo Matsumura, Yoshiki Tabuchi, Noriaki Tsubota, Juro Takahashi · 2007 · PubMed
27. Cytochrome b5 shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy
    Věra Černá, Barbora Mrázová, Michaela Moserová, Václav Martínek, Petr Hodek, Jiřı́ Hudeček, Eva Frei, Marie Stiborová · 2011 · Biochemical Pharmacology
28. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer
    Joanne Kotsopoulos, Allison F. Vitonis, Kathryn L. Terry, Immaculata De Vivo, Daniel William Cramer, Susan E. Hankinson, Shelley S. Tworoger · 2008 · Cancer Causes & Control
29. Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry
    Jessica L. Gleason, Fasil Tekola Ayele, Rajeshwari Sundaram, Stefanie N. Hinkle, Yassaman Vafai, Germaine M. Buck Louis, Nicole Gerlanc, Melissa M. Amyx, Alaina M. Bever, Melissa M. Smarr et al. · 2021 · JAMA Network Open
30. Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population
    Samar Ismail Hamdy, Masahiro Hiratsuka, Kaori Narahara, Naomi Endo, Mervat M. El‐Enany, Nadia Moursi, Mohammed Ahmed, Michinao Mizugaki · 2003 · British Journal of Clinical Pharmacology
31. Association of Genetic Polymorphisms with Serum Estrogens Measured Multiple Times During a 2-Year Period in Premenopausal Women
    Galina Lurie, Gertraud Maskarinec, Rudolf Kaaks, Frank Z. Stanczyk, Loı̈c Le Marchand · 2005 · Cancer Epidemiology Biomarkers & Prevention
32. CYP1A2 Genetic Variation, Coffee Intake, and Kidney Dysfunction
    Sara Mahdavi, Paolo Palatini, Ahmed El‐Sohemy · 2023 · JAMA Network Open
33. Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy
    Sebastian C. Holst, Amandine Valomon, Hans‐Peter Landolt · 2015 · The Annual Review of Pharmacology and Toxicology
34. Estrogen pathway polymorphisms and mammographic density.
    Isabelle Dumas, Caroline Diorio · 2011 · PubMed
35. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
    Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucíja Peterlin Mašič, Aleš Mrhar, Vita Dolžan · 2009 · Drug Metabolism and Disposition
36. Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status
    Erika Bågeman, Christian Ingvar, Carsten Rose, Helena Jernström · 2008 · Cancer Epidemiology Biomarkers & Prevention
37. Gender and ethnicity modify the association between the CYP1A2 rs762551 polymorphism and habitual coffee intake: evidence from a meta-analysis
    Sabri Denden, B. Bouden, Amel Haj Khelil, Jemni Ben Chibani, M.H. Hamdaoui · 2016 · Genetics and Molecular Research
38. Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes
    Na Gao, Xin Tian, Yan Fang, Jun Zhou, Haifeng Zhang, Qiang Wen, Lin-Jing Jia, Jie Gao, Bao Sun, Jingyao Wei et al. · 2016 · European Journal of Pharmaceutical Sciences
39. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2
    Yu‐Hsuan Chuang, Christina M. Lill, Pei‐Chen Lee, Johnni Hansen, Christina Funch Lassen, Lars Bertram, Naomi Greene, Janet S. Sinsheimer, Beate R. Ritz · 2016 · Neuroepidemiology
40. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
    István Kiss, Zsuzsa Orsós, Katalin Gombos, Barna Bogner, András Csejtei, Antal Tibold, Zsuzsa Varga, Emese Pázsit, Ingrid Magda, Annamária Zólyomi et al. · 2007 · PubMed
41. A population phenotyping study of three drug‐metabolizing enzymes in Kyushu, Japan, with use of the caffeine test
    Junji Saruwatari, Kazuko Nakagawa, Junichi Shindo, Takahiro Tajiri, Masaki Fujieda, Hiroshi Yamazaki, Tetsuya Kamataki, Takashi Ishizaki · 2002 · Clinical Pharmacology & Therapeutics
42. CYP1A2*1D and *1F Polymorphisms Have a Significant Impact on Olanzapine Serum Concentrations
    Fabian Czerwensky, Stefan Leucht, Werner Steimer · 2014 · Therapeutic Drug Monitoring
43. CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico
    Fabiola Castorena‐Torres, Ania Mendoza‐Cantú, Mario Bermúdez de León, Bulmaro Cisneros, Omar Zapata‐Pérez, Lizbeth López‐Carrillo, Juan E. Salinas, Arnulfo Albores · 2005 · Toxicology Letters
44. Origins of Individual Variability in P4501A Induction
    Qiang Ma, Anthony Y.H. Lu · 2003 · Chemical Research in Toxicology
45. Genetic Profile of Patients with Epilepsy on First-Line Antiepileptic Drugs and Potential Directions for Personalized Treatment
    Sandeep Grover, Mandaville Gourie‐Devi, Ruchi Baghel, Sangeeta Sharma, Kiran Bala, Meena Gupta, Krishnamoorthy Narayanasamy, Binuja Varma, Meenal Gupta, Kavita Kaur et al. · 2010 · Pharmacogenomics
46. Genetic Determinants of Clozapine-Induced Metabolic Side Effects
    Kamini Vasudev, Yun‐Hee Choi, Ross M.G. Norman, Richard B. Kim, Ute I. Schwarz · 2016 · The Canadian Journal of Psychiatry
47. Polymorphic Variants of Cytochrome P450
    Ann K. Daly · 2015 · Advances in pharmacology
48. The impact of CYP allelic variation on antidepressant metabolism: a review
    John Logan Black, Dennis J. O’Kane, David A. Mrazek · 2007 · Expert Opinion on Drug Metabolism & Toxicology
49. Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis
    Michael David Wiese, Matthew Schnabl, Catherine O’Doherty, Llewellyn DJ Spargo, Michael Joseph Sorich, Leslie G. Cleland, Susanna Proudman · 2012 · Arthritis Research & Therapy
50. The Effects of a Polymorphism in the Cytochrome P450 CYP1A2 Gene on Performance Enhancement with Caffeine in Recreational Cyclists
    Haya A. AlGrain, Rebecca M. Thomas, Andres E. Carrillo, Emily J. Ryan, Chul-Ho Kim, Robert B. II Lettan, Edward J. Ryan · 2015 · Journal of Caffeine Research
51. POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS
    Masashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii · 2004 · Drug Metabolism and Disposition
52. Differential Pharmacokinetics of Theophylline in Elderly Patients
    Akihiro Ohnishi, Motokazu Kato, Jun Kojima, Hideki Ushiama, Maki Yoneko, Hiroyuki Kawai · 2003 · Drugs & Aging
53. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma
    Auemduan Prawan, Veerapol Kukongviriyapan, Wichittra Tassaneeyakul, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi · 2005 · European Journal of Cancer Prevention
54. Simultaneous Genotyping of Nine Polymorphisms in Xenobiotic-Metabolizing Enzymes by Multiplex PCR Amplification and Single Base Extension
    Ad M. Knaapen, Hans B. Ketelslegers, Ralph W.H. Gottschalk, Rob G. J. H. Janssen, Aimee D. C. Paulussen, Hubert J.M. Smeets, Roger Godschalk, Frederik‐Jan van Schooten, Jos C. S. Kleinjans, Joost H.M. van Delft · 2004 · Clinical Chemistry
55. Pharmacogenomics of anticoagulants: steps toward personal dosage
    Ann K. Daly · 2009 · Genome Medicine
56. Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
    Giovanna Gentile, Marina Borro, Noemi Lala, Serena Missori, Maurizio Simmaco, Paolo Martelletti · 2010 · The Journal of Headache and Pain
57. The CYP1A2-164A→C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans
    Harald J.J. Moonen, Leopold G.J.B. Engels, Jos C. S. Kleinjans, Theo M. C. M. de Kok · 2005 · Cancer Letters
58. Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene
    Siow‐Ann Chong, Ene‐Choo Tan, Chay Hoon Tan, Mythily · 2003 · Journal of Psychiatry and Neuroscience
59. Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial
    Carissa Gardiner, Jonathon J. S. Weakley, Louise M. Burke, Francesca Fernandez, Rich D. Johnston, Josh Leota, Suzanna Russell, Gabriella Munteanu, ANDREW D. TOWNSHEND, Shona Leigh Halson · 2024 · SLEEP
60. Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy
    Keiji Takata, Junji Saruwatari, Naoyuki Nakada, Mizuna Nakagawa, Koichiro Fukuda, Fujiho Tanaka, Shinobu Takenaka, 三原 修一, Toru Marubayashi, Kazuko Nakagawa · 2005 · European Journal of Clinical Pharmacology
61. Where Failure Is Not an Option –Personalized Medicine in Astronauts
    Julia Stingl, Susanne Welker, Gunther Hartmann, Volker Damann, Ruppert Gerzer · 2015 · PLoS ONE
62. Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C > A CYP1A2 genotypes
    Higor Spineli, Maryssa Pontes Pinto, Bruna Priscila dos Santos, Adriano Eduardo Lima‐Silva, Rômulo Bertuzzi, Daniel Leite Góes Gitaí, Gustavo Gomes de Araújo · 2020 · Scandinavian Journal of Medicine and Science in Sports
63. Prevalence of caffeine consumers, daily caffeine consumption, and factors associated with caffeine use among active duty United States military personnel
    Joseph J. Knapik, Ryan A. Steelman, Daniel W. Trone, Emily Kristin Farina, Harris R. Lieberman · 2022 · Nutrition Journal
64. Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study
    Maurizio Facheris, Nicole K. Schneider, Timothy G. Lesnick, Mariza de Andrade, Julie M. Cunningham, Walter A. Rocca, Demetrius M. Maraganore · 2008 · Movement Disorders
65. Genetic Polymorphism of Human Cytochrome P450 Involved in Drug Metabolism
    Kiyoshi Nagata, Yasushi Yamazoe · 2002 · Drug Metabolism and Pharmacokinetics
66. Defining drug disposition determinants: a pharmacogenetic–pharmacokinetic strategy
    David A. Katz, Bernard P. Murray, Anahita Bhathena, Leonardo Sahelijo · 2008 · Nature Reviews Drug Discovery
67. Introduction to Drug Metabolism
    Ulrich M. Zanger · 2012
68. High Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 Genotype
    Elizabeth C. Lowcock, Michelle Cotterchio, Laura N. Anderson, Beatrice A. Boucher, Ahmed El‐Sohemy · 2013 · Nutrition and Cancer
69. Role of CYP1A2 polymorphisms in breast cancer risk in women
    IMENE AYARI, Ugo Fedeli, Saâd Saguem, Samir Hidar, Saida Khlifi, Sofia Pavanello · 2012 · Molecular Medicine Reports
70. CYP1A2 Genetic Polymorphisms are Associated with Treatment Response to the Antidepressant Paroxetine
    Keh‐Ming Lin, Hsiao‐Hui Tsou, I‐Ju Tsai, Mei‐Chun Hsiao, Chin‐Fu Hsiao, Chia-Yih Liu, Winston W. Shen, Hwa‐Sheng Tang, Chun‐Kai Fang, Chi‐Shin Wu et al. · 2010 · Pharmacogenomics
71. Coffee consumption and risk of cardiovascular events in hypertensive patients. Results from the HARVEST
    Paolo Palatini, Claudio Fania, Lucio Mos, Guido Garavelli, Adriano Mazzer, Susanna Cozzio, Francesca Saladini, Edoardo Casiglia · 2016 · International Journal of Cardiology
72. The Development of a Personalised Training Framework: Implementation of Emerging Technologies for Performance
    Craig Pickering, John Kiely · 2019 · Journal of Functional Morphology and Kinesiology
73. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan
    Hui‐Ling Chiou, Ming‐Fang Wu, Wen-Pin Chien, Ya‐Wen Cheng, Ruey‐Hong Wong, Chin‐Yi Chen, Torng-Sen Lin, Huei Lee · 2005 · Cancer Letters
74. Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position −2964 in the 5′-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia
    Kazutaka Shimoda, Toshiyuki Someya, Sachiyo Morita, Genta Hirokane, Aya Yokono, Saburo Takahashi, Masako Okawa · 2002 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
75. Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene–gene and gene–environment interactions for disease susceptibility
    Alexey Polonikov, Vladimir P. Ivanov, Maria A. Solodilova · 2009 · Journal of Human Genetics
76. Genetic polymorphisms in estrogen metabolism and breast cancer risk in case–control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians
    Naoki Shimada, Motoki Iwasaki, Yoshio Kasuga, Shiro Yokoyama, Hiroshi Onuma, Hideki Nishimura, Ritsu Kusama, Gerson Shigeaki Hamada, Inês Nobuko Nishimoto, Hirofumi Iyeyasu et al. · 2009 · Journal of Human Genetics
77. Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of ‘smokers’ paradox'
    Kyung Woo Park, Si‐Hyuck Kang, Jeehoon Kang, Ki‐Hyun Jeon, Jin Joo Park, Jung‐Kyu Han, Jin‐Sin Koh, Sang Eun Lee, Han‐Mo Yang, Hae‐Young Lee et al. · 2012 · Heart
78. Are low doses of caffeine as ergogenic as higher doses? A critical review highlighting the need for comparison with current best practice in caffeine research
    Craig Pickering, John Kiely · 2019 · Nutrition
79. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies
    Hongge Wang, Zhi Zhang, Sugui Han, Yujuan Lu, Fumin Feng, Juxiang Yuan · 2012 · BMC Cancer
80. Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia
    Vidya Perera, Annette S. Gross, Thomas M. Polasek, Qin Yan, Gauri G. Rao, Alan Forrest, Junzhe Xu, Andrew J. McLachlan · 2013 · Expert Opinion on Drug Metabolism & Toxicology
81. Effect of caffeine ingestion on time trial performance in cyclists: a systematic review and meta-analysis
    Bin Chen, Li Ding, Qiyang Qin, Tze‐Huan Lei, Olivier Girard, Yinhang Cao · 2024 · Journal of the International Society of Sports Nutrition
82. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics
    X. Hart, G. Gründer, N. Ansermot, A. Conca, E. Corruble, S. Crettol, P. Cumming, G. Hefner, A. Frajerman, O. Howes et al. · 2024 · World Journal of Biological Psychiatry
83. The Effect of Oral Contraceptives on the Pharmacokinetics of Melatonin in Healthy Subjects With CYP1A2 g.‐163C>A Polymorphism
    Johanna Hilli, Tuomas Korhonen, Miia Turpeinen, Juho Hokkanen, Sampo Mattila, Kari Laine · 2008 · The Journal of Clinical Pharmacology
84. Pharmacogenetic considerations in the treatment of psychiatric disorders
    Falk W. Lohoff, Thomas N. Ferraro · 2010 · Expert Opinion on Pharmacotherapy
85. Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2
    Johannes Matthaei, Mladen Vassilev Tzvetkov, Jakob Strube, Daniel B. Sehrt, Cordula Sachse-Seeboth, Jacob Hjelmborg, Sören Möller, Ulrich Halekoh, Ute Hofmann, Matthias Georg Schwab et al. · 2016 · Clinical Pharmacology & Therapeutics
86. Genetic Polymorphisms in ADORA2A and CYP1A2 Influence Caffeine’s Effect on Postprandial Glycaemia
    Nile F. Banks, Patrick M. Tomko, Ryan J. Colquhoun, Tyler W.D. Muddle, Sam R. Emerson, Nathaniel D.M. Jenkins · 2019 · Scientific Reports
87. Association of cigarette smoking with the risk of ovarian cancer
    Sai Yi Pan, Anne‐Marie Ugnat, Yang Mao, Shi Wu Wen, Kenneth C. Johnson · 2004 · International Journal of Cancer
88. Effects of Caffeine Chewing Gum Supplementation on Exercise Performance: A Systematic Review and Meta-analysis
    Barreto, G., Loureiro, L. M. R., Reis, C. E. G., Saunders, B. · 2023 · European Journal of Sport Science
89. Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors
    Kristina Probst-Schendzielorz, Roberto Viviani, Julia Stingl · 2015 · Expert Opinion on Drug Metabolism & Toxicology
90. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status
    Maria Simonsson, Viktoria Söderlind, Maria Henningson, Maria Hjertberg, Carsten Rose, Christian Ingvar, Helena Jernström · 2013 · Cancer Causes & Control
91. CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: a systematic review
    Jozo Grgić, Craig Pickering, Juan Del Coso, Brad Jon Schoenfeld, Pavle Mikulić · 2020 · European Journal of Nutrition
92. Genetics of caffeine and brain-related outcomes – a systematic review of observational studies and randomized trials
    Angeliki Kapellou, Alexandra King, Catherine Graham, Leta Pilić, Yiannis Mavrommatis · 2023 · Nutrition Reviews
93. Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors
    Tzu‐Hua Wu, Chih-Chiang Chiu, Winston W. Shen, Fang-Wei Lin, Li‐Hsuan Wang, Hsiang-Yu Chen, Mong‐Liang Lu · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
94. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer
    Hiromasa Tsukino, Yoshiki Kuroda, Hiroyuki Nakao, Hirohisa Imai, Hisato Inatomi, Yukio Osada, Takahiko Katoh · 2004 · Journal of Cancer Research and Clinical Oncology
95. Pharmacogenetics as a tool in the therapy of schizophrenia
    Bob Wilffert, Rianne J. Zaal, J. R. B. J. Brouwers · 2005 · Pharmacy World & Science
96. Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine
    Lucia Aronica, José María Ordovás, Andrey Volkov, Joseph J. Lamb, P. Michael Stone, Deanna M. Minich, Michelle Leary, Monique Class, Dina Metti, Ilona A. Larson et al. · 2022 · Nutrients
97. A Conceptual Framework for Studying and Investing in Precision Nutrition
    Steven H. Zeisel · 2019 · Frontiers in Genetics
98. An investigation of mammographic density and gene variants in healthy women
    Gertraud Maskarinec, Galina Lurie, Andrew E. Williams, Loı̈c Le Marchand · 2004 · International Journal of Cancer
99. Pharmacogenetics for the Individualization of Psychiatric Treatment
    Maria Jesús Arranz, David Andrew Collier, Robert W Kerwin · 2001 · American Journal of PharmacoGenomics
100. The Influence of CYP1A2 Genotype in the Blood Pressure Response to Caffeine Ingestion Is Affected by Physical Activity Status and Caffeine Consumption Level
     Soares, Rogerio Nogueira, Schneider, Augusto, Valle, Sandra Costa, Schenkel, Paulo Cavalheiro · 2018 · Vascular Pharmacology